Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Microscopic Peptide Droplets Show Promise in Reducing Colorectal Tumor Growth

1w ago September 4, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

Scientists from Nanyang Technological University, Singapore, have developed peptide droplets that significantly reduce colorectal tumor growth in mice. This advancement in cancer treatment could have implications for healthcare innovations in Iran, particularly in oncology.

🔍 Quick Context Guide
💡 Bottom Line: The development of peptide droplets for cancer treatment represents a significant step forward in oncology research that could have far-reaching implications.

👥 Key Players

Nanyang Technological University (NTU Singapore) MENTIONED
Research Institution
"NTU Singapore is a leading research institution that contributes to advancements in medical science, which can influence healthcare innovations in Iran."

📰 What Happened

Scientists at NTU Singapore have created microscopic peptide droplets that deliver gene-silencing molecules to cancer cells, resulting in a 67% reduction in colorectal tumor growth in mice. This breakthrough could enhance cancer treatment options.

  • The system uses small interfering RNA (siRNA) to target proteins that help cancer cells evade the immune system.
  • The findings are still in the experimental stage, having only been tested in mice.

💡 Why It Matters

🇮🇷 For Iran: This development could lead to new cancer treatment options in Iran, where cancer rates are rising and healthcare resources are limited.
🌍 Regional: Improved cancer therapies could enhance healthcare systems in the region, potentially reducing the burden of disease.
🌐 International: This research may attract international collaboration and investment in cancer research, influencing global health policies.

📚 Background

Colorectal cancer is one of the most common cancers worldwide, and innovative treatments are urgently needed to improve patient outcomes.

Cancer treatment advancements Gene therapy
📡 Source: NEUTRAL
📊 Confidence: 70%
The information comes from a scientific research context, which typically aims for objectivity in reporting findings.

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of gene-silencing molecules into cancer and immune cells, reducing the growth of hard-to-treat colorectal tumors by about 67% in mice. The patent-pending system uses small interfering RNA, or siRNA, to disrupt the production of two proteins that cancer cells exploit to evade attacks by the immune system.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →